Apixaban shows effectiveness with or without warfarin therapy

08/5/2013 | TCTMD.com

A study in the American Heart Journal found that apixaban had the same effect on patients with atrial fibrillation whether or not they had been treated previously with warfarin. The subanalysis of the ARISTOTLE trial found that warfarin-naive patients treated with apixaban spent a median 61.4% time in therapeutic range, while those who had previously received warfarin were in therapeutic range a median 69.1% of treatment time. "In the present prospective comparison, prior [warfarin] exposure did not modify the effect of apixaban relative to warfarin for most key efficacy and safety outcomes," researchers wrote.

View Full Article in:

TCTMD.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Litigation
Center for Science in the Public Interest
Washington, DC
Health Plan CEO - Oregon
Trillium Community Health Plan
Eugene, OR
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Associate General Counsel
Patient-Centered Outcomes Research Institute
Washington, D.C , DC